Positive rates for rubella antibody in pregnant women and benefit of post-partum vaccination in a Japanese perinatal center
Positive rates for rubella antibody in pregnant women and benefit of post-partum vaccination in a Japanese perinatal center
复制标题
DOI:
10.1111/j.1447-0756.2007.00689.x
复制
发表时间:
2008-04-01
影响因子:
1.6
通讯作者:
Hirahara, Fumiki
中科院分区:
文献类型:
--
作者:
Okuda, Mika;Yamanaka, Michiko;Hirahara, Fumiki
Aim: This study of pregnant women was undertaken to clarify their immune status for rubella and to evaluate the efficacy of, and adverse reaction to, post-partum rubella vaccination.Methods: We determined the levels of both rubella antibody by hemagglutination inhibition test and IgM antibody by enzyme-linked immunosorbent assay in the first gestational trimester and surveyed the positive rates for rubella antibody in pregnant women at our perinatal center; we recommended post-partum vaccination for women with poor immune status. We also evaluated the effectiveness of the vaccine and any adverse reaction.Results: Among 2741 pregnant women, 185 cases (6.7%) were seronegative for rubella virus. This rate was especially high (12.4%) in the population who had opted out of the vaccination because of a change in Japanese government policy. A total of 30 cases (1.1%) were positive or false-positive for IgM antibody, but no congenital rubella syndrome (CRS) developed. The seropositive rate was 93.3% in total, but this figure includes those who required post-partum vaccination (558 cases or 20.3%) because their titers were 16x or lower. Among 145 cases who received post-partum rubella vaccine, no severe adverse reaction was detected, and in all 37 cases with hemagglutination inhibition antibody titers of 8x or lower, the efficacy rate was 100%.Conclusions: It is necessary to appropriately evaluate the CRS risk. Also, we need to emphasize the importance and safety of post-partum rubella vaccination in Japan.